BRAMPTON, Ont. — Loblaw beat analyst forecasts for the quarter, the Financial Post reports, boosted by strong sales in its pharmacy business at Shoppers Drug Mart, which the retail group acquired this year. Same-store front sales grew 2.5% at Shoppers, while Loblaw saw overall 1.6% growth. Loblaw’s revenue rose 36% to $13.6 billion, a quarter of that coming from Shoppers Drug Mart. The merger saved Loblaw about $44 million in the quarter, but also cost it $46 million in restructuring and reorganization expenses. Net earnings fell to $142 million from $150 million. Adjusted basic net earnings was 90 cents per share, slightly ahead of the average forecast of 87 cents.
Shoppers deal buoys Loblaw results
Most Recent
Most Read
Gillfor partners with IKO in exclusive distribution deal
Tue, December 05th, 2023
Mastermind Toys finds a buyer
Tue, December 05th, 2023
Learn how to drive appliance & kitchen sales in latest issue of Dealer News
Tue, December 05th, 2023
RONA shares strategy, new look for its dealers, at Montreal buying show
Mon, December 04th, 2023
Gawtrey announces retirement from Home Hardware
Mon, December 04th, 2023
Vista Railing expands sales team in Ontario and U.S.
Mon, December 04th, 2023
French home improvement supplier Alpagroup sets up in North America
Fri, December 01st, 2023
LBMAO’s AGM and gala brings Ontario industry members together
Fri, December 01st, 2023
Canadian shoppers to spend 15 percent more this holiday season: Retail Council of Canada
Fri, December 01st, 2023
Rainbow Bridge car explosion was a lumber dealer, not a terrorist
Thu, November 30th, 2023